The ROE (Return on Equity) of Chong Kun Dang Pharmaceutical Corp (185750.KS) is 12.20%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 12.20% |
| 2023-12-31 | 26.05% |
| 2022-12-31 | 13.01% |
| 2021-12-31 | 7.55% |
| 2020-12-31 | 16.62% |
| 2019-12-31 | 11.38% |
| 2018-12-31 | 9.89% |
| 2017-12-31 | 13.39% |
| 2016-12-31 | 11.56% |
| 2015-12-31 | -2.15% |